| 1X8B | A: | STRUCTURE OF HUMAN WEE1A KINASE: KINASE DOMAIN COMPLEXED WITH INHIBITOR PD0407824 |
| 1YI6 | A:; B: | C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533) |
| 1YOJ | A:; B: | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN |
| 1YOL | A:; B: | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675 |
| 1YOM | A:; B: | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A |
| 1YRP | A:; B: | CATALYTIC DOMAIN OF HUMAN ZIP KINASE PHOSPHORYLATED AT THR265 |
| 1YVJ | A: | CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE |
| 1ZRZ | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ATYPICAL PROTEIN KINASE C-IOTA |
| 2A19 | B:; C: | PKR KINASE DOMAIN- EIF2ALPHA- AMP-PNP COMPLEX. |
| 2A1A | B: | PKR KINASE DOMAIN-EIF2ALPHA COMPLEX |
| 2A2A | A:; B:; C:; D: | HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE |
| 2AC3 | A: | STRUCTURE OF HUMAN MNK2 KINASE DOMAIN |
| 2B7A | A:; B: | THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR |
| 2BIK | B: | HUMAN PIM1 PHOSPHORYLATED ON SER261 |
| 2BMC | A:; B:; C:; D:; E:; F: | AURORA-2 T287D T288D COMPLEXED WITH PHA-680632 |
| 2BUJ | A:; B: | CRYSTAL STRUCTURE OF THE HUMAN SERINE-THREONINE KINASE 16 IN COMPLEX WITH STAUROSPORINE |
| 2BVA | A:; B: | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 |
| 2BZH | B: | CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1 |
| 2BZI | B: | CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU2 |
| 2BZJ | A: | CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU3 |
| 2C30 | A: | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 6 |
| 2CDZ | A: | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH CGP74514A |
| 2CKE | A:; B:; C:; D: | HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR |
| 2CLQ | A:; B: | STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5 |
| 2CN5 | A: | CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP |
| 2CN8 | A: | CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH DEBROMOHYMENIALDISINE |
| 2DQ7 | X: | CRYSTAL STRUCTURE OF FYN KINASE DOMAIN COMPLEXED WITH STAUROSPORINE |
| 2DYL | A: | CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 ACTIVATED MUTANT (S287D, T291D) |
| 2F57 | A:; B: | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5 |
| 2GSF | A: | THE HUMAN EPHA3 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION |
| 2H6D | A: | PROTEIN KINASE DOMAIN OF THE HUMAN 5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (AMPK ALPHA-2 CHAIN) |
| 2HW6 | A:; B: | CRYSTAL STRUCTURE OF MNK1 CATALYTIC DOMAIN |
| 2HW7 | A: | CRYSTAL STRUCTURE OF MNK2-D228G IN COMPLEX WITH STAUROSPORINE |
| 2I6L | A:; B: | CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 6 (MAPK6) |
| 2IN6 | A: | WEE1 KINASE COMPLEX WITH INHIBITOR PD311839 |
| 2IO6 | A: | WEE1 KINASE COMPLEXED WITH INHIBITOR PD330961 |
| 2IVS | A:; B: | CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED RET TYROSINE KINASE DOMAIN |
| 2IVT | A: | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN |
| 2IVU | A: | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR ZD6474 |
| 2IVV | A: | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR PP1 |
| 2IWI | A:; B: | CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1 |
| 2J0I | A: | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 |
| 2J2I | B: | CRYSTAL STRUCTURE OF THE HUMAB PIM1 IN COMPLEX WITH LY333531 |
| 2J4Z | A:; B: | STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626 |
| 2J50 | A:; B: | STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-739358 |
| 2OU7 | A: | STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1 |
| 2OWB | A: | STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1 |
| 2Q0N | A: | STRUCTURE OF HUMAN P21 ACTIVATING KINASE 4 (PAK4) IN COMPLEX WITH A CONSENSUS PEPTIDE |
| 2QLU | A: | CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE II KINASE DOMAIN FROM HUMAN |
| 2QO2 | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, APO STRUCTURE |
| 2QO7 | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, AMP-PNP BOUND |
| 2QO9 | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, PHOSPHORYLATED, AMP-PNP BOUND |
| 2QOB | A: | HUMAN EPHA3 KINASE DOMAIN, BASE STRUCTURE |
| 2QOC | A: | HUMAN EPHA3 KINASE DOMAIN, PHOSPHORYLATED, AMP-PNP BOUND STRUCTURE |
| 2QOD | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y602F MUTANT |
| 2QOF | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F MUTANT |
| 2QOI | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F DOUBLE MUTANT |
| 2QOK | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:S768A TRIPLE MUTANT |
| 2QOL | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596:Y602:S768G TRIPLE MUTANT |
| 2QON | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742A TRIPLE MUTANT |
| 2QOO | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742F TRIPLE MUTANT |
| 2QOQ | A: | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, BASE, AMP-PNP BOUND STRUCTURE |
| 2R4B | A:; B: | ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR |
| 2RKU | A: | STRUCTURE OF PLK1 IN COMPLEX WITH BI2536 |
| 2V7O | A: | CRYSTAL STRUCTURE OF HUMAN CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE II GAMMA |
| 2VN9 | A:; B: | CRYSTAL STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA ISOFORM 1, CAMKD |
| 2VWI | A:; B:; C:; D: | STRUCTURE OF THE OSR1 KINASE, A HYPERTENSION DRUG TARGET |
| 2VWU | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VWV | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VWW | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VWX | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VWY | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VWZ | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VX0 | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VX1 | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2VZ6 | A:; B: | STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE II ALPHA (CAMK2A) IN COMPLEX WITH INDIRUBIN E804 |
| 2W0J | A: | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555, A SPECIFIC INHIBITOR |
| 2W1I | A:; B: | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
| 2W7X | A: | CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019 |
| 2WEL | A: | CRYSTAL STRUCTURE OF SU6656-BOUND CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II DELTA IN COMPLEX WITH CALMODULIN |
| 2WQM | A: | STRUCTURE OF APO HUMAN NEK7 |
| 2WQN | A: | STRUCTURE OF ADP-BOUND HUMAN NEK7 |
| 2WTC | A: | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR |
| 2WTD | A: | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR |
| 2WTI | A: | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR |
| 2WTJ | A: | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR |
| 2WTK | C:47-310; F:45-310 | STRUCTURE OF THE HETEROTRIMERIC LKB1-STRADALPHA-MO25ALPHA COMPLEX |
| 2X2K | A: | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR |
| 2X2L | A: | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR |
| 2X2M | A:; B: | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR |
| 2X4F | A: | THE CRYSTAL STRUCTURE OF THE HUMAN MYOSIN LIGHT CHAIN KINASE LOC340156. |
| 2X4Z | A: | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH PF-03758309 |
| 2X7F | A:; B:; C:; D:; E: | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2- AND NCK-INTERACTING KINASE WITH WEE1CHK1 INHIBITOR |
| 2X9E | A: | HUMAN MPS1 IN COMPLEX WITH NMS-P715 |
| 2X9F | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2XA4 | A:; B: | INHIBITORS OF JAK2 KINASE DOMAIN |
| 2XB7 | A: | STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH NVP-TAE684 |
| 2XBA | A: | STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PHA-E429 |
| 2XBJ | A: | CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR |
| 2XIK | A: | STRUCTURE OF HUMAN YSK1 (YEAST SPS1-STE20-RELATED KINASE 1) |
| 2XK9 | A: | STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 (CHK2) IN COMPLEX WITH INHIBITOR PV1533 |
| 2XM9 | A: | STRUCTURE OF A SMALL MOLECULE INHIBITOR WITH THE KINASE DOMAIN OF CHK2 |
| 2XP2 | A: | STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066) |
| 2XVD | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2Y7J | A:; B:; C:; D: | STRUCTURE OF HUMAN PHOSPHORYLASE KINASE, GAMMA 2 |
| 2YAC | A: | CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH NMS-P937 |
| 2YCF | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR PV1531 |
| 2YCQ | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR PV1115 |
| 2YCR | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR PV976 |
| 2YCS | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV788 |
| 2YFX | A: | STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB |
| 2YHV | A: | STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE |
| 2YIQ | A: | STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR PV1322 |
| 2YIR | A: | STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR PV1352 |
| 2YIT | A: | STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV1162, A NOVEL INHIBITOR |
| 2YJR | A: | STRUCTURE OF F1174L MUTANT ANAPLASTIC LYMPHOMA KINASE |
| 2YJS | A: | STRUCTURE OF C1156Y MUTANT ANAPLASTIC LYMPHOMA KINASE |
| 2YN8 | A:; B: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 2YZA | A: | CRYSTAL STRUCTURE OF KINASE DOMAIN OF HUMAN 5'-AMP-ACTIVATED PROTEIN KINASE ALPHA-2 SUBUNIT MUTANT (T172D) |
| 2Z2W | A: | HUMAN WEE1 KINASE COMPLEXED WITH INHIBITOR PF0335770 |
| 2Z7Q | A: | CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK-1 BOUND TO AMP-PCP |
| 2Z7R | A: | CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK1 BOUND TO STAUROSPORINE |
| 2Z7S | A: | CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK1 BOUND TO PURVALNOL A |
| 2ZMC | A: | CRYSTAL STRUCTURE OF HUMAN MITOTIC CHECKPOINT KINASE MPS1 CATALYTIC DOMAIN APO FORM |
| 2ZMD | A: | CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN T686A MUTANT IN COMPLEX WITH SP600125 INHIBITOR |
| 2ZV2 | A: | CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2, BETA, CAMKK2 KINASE DOMAIN IN COMPLEX WITH STO-609 |
| 3A60 | A:; B: | CRYSTAL STRUCTURE OF UNPHOSPHORYLATED P70S6K1 (FORM I) |
| 3A62 | A: | CRYSTAL STRUCTURE OF PHOSPHORYLATED P70S6K1 |
| 3A7F | A: | HUMAN MST3 KINASE |
| 3A7G | A:; B: | HUMAN MST3 KINASE |
| 3A7H | A:; B: | HUMAN MST3 KINASE IN COMPLEX WITH ATP |
| 3A7I | A: | HUMAN MST3 KINASE IN COMPLEX WITH ADENINE |
| 3A7J | A: | HUMAN MST3 KINASE IN COMPLEX WITH MNADP |
| 3A8W | A:; B: | CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN |
| 3A8X | A:; B: | CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN |
| 3ALN | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN NON-PHOSPHORYLATED MKK4 KINASE DOMAIN COMPLEXED WITH AMP-PNP |
| 3AOX | A: | X-RAY CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CH5424802 |
| 3AQV | A: | HUMAN AMP-ACTIVATED PROTEIN KINASE ALPHA 2 SUBUNIT KINASE DOMAIN (T172D) COMPLEXED WITH COMPOUND C |
| 3BHH | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B) |
| 3BHY | A: | CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) IN COMPLEX WITH A BETA-CARBOLINE LIGAND |
| 3BI6 | A: | WEE1 KINASE COMPLEX WITH INHIBITOR PD352396 |
| 3BIZ | A: | WEE1 KINASE COMPLEX WITH INHIBITOR PD331618 |
| 3BLQ | A: | CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH ATP |
| 3BLR | A: | CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH FLAVOPIRIDOL |
| 3BQR | A: | CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) IN COMPLEX WITH AN IMIDAZO-PYRIDAZINE LIGAND |
| 3C0G | A:; B: | CASK CAM-KINASE DOMAIN- 3'-AMP COMPLEX, P1 FORM |
| 3C0H | A:; B: | CASK CAM-KINASE DOMAIN- AMPPNP COMPLEX, P1 FORM |
| 3C0I | A: | CASK CAM-KINASE DOMAIN- 3'-AMP COMPLEX, P212121 FORM |
| 3C4C | A:; B: | B-RAF KINASE IN COMPLEX WITH PLX4720 |
| 3CEK | A: | CRYSTAL STRUCTURE OF HUMAN DUAL SPECIFICITY PROTEIN KINASE (TTK) |
| 3CKW | A: | CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3, STK24) |
| 3CKX | A: | CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3, STK24) IN COMPLEX WITH STAUROSPORINE |
| 3COK | A:; B: | CRYSTAL STRUCTURE OF PLK4 KINASE |
| 3COM | A:; B: | CRYSTAL STRUCTURE OF MST1 KINASE |
| 3CQE | A: | WEE1 KINASE COMPLEX WITH INHIBITOR PD074291 |
| 3CR0 | A: | WEE1 KINASE COMPLEX WITH INHIBITOR PD259_809 |
| 3DAK | A:; B:; C:; D: | CRYSTAL STRUCTURE OF DOMAIN-SWAPPED OSR1 KINASE DOMAIN |
| 3DBQ | A: | CRYSTAL STRUCTURE OF TTK KINASE DOMAIN |
| 3DBS | A:726-1091 | STRUCTURE OF PI3K GAMMA IN COMPLEX WITH GDC0941 |
| 3DLS | A:; B:; C:; D:; E:; F: | CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP |
| 3DTC | A: | CRYSTAL STRUCTURE OF MIXED-LINEAGE KINASE MLK1 COMPLEXED WITH COMPOUND 16 |
| 3DZQ | A: | HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH INHIBITOR AWL-II-38.3 |
| 3E62 | A: | FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS |
| 3E63 | A: | FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS |
| 3E64 | A: | FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS |
| 3ENM | A:; B:; C:; D: | THE STRUCTURE OF THE MAP2K MEK6 REVEALS AN AUTOINHIBITORY DIMER |
| 3EYG | A: | CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES |
| 3EYH | A: | CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES |
| 3FC2 | A: | PLK1 IN COMPLEX WITH BI6727 |
| 3FME | A: | CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6 (MEK6) ACTIVATED MUTANT (S207D, T211D) |
| 3FUP | A:; B: | CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES |
| 3GFW | A: | CRYSTAL STRUCTURE OF HUMAN DUAL SPECIFICITY PROTEIN KINASE (TTK) IN COMPLEX WITH A PYROLO-PYRIDIN LIGAND |
| 3GGF | A:; B: | CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE MST4 IN COMPLEX WITH AN QUINAZOLIN |
| 3H9F | A: | CRYSTAL STRUCTURE OF HUMAN DUAL SPECIFICITY PROTEIN KINASE (TTK) IN COMPLEX WITH A PYRIMIDO-DIAZEPIN LIGAND |
| 3H9O | A: | PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK-1) IN COMPLEX WITH COMPOUND 9 |
| 3HMN | A: | CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH ATP |
| 3HMO | A: | CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH THE INHIBITOR STAUROSPORINE |
| 3HMP | A: | CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH A QUINAZOLIN LIGAND COMPOUND 4 |
| 3HRC | A: | CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ATP |
| 3HRF | A: | CRYSTAL STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN ALLOSTERIC ACTIVATOR BOUND TO THE PIF-POCKET |
| 3IO7 | A: | 2-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2 |
| 3IOK | A: | 2-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2 |
| 3JY9 | A: | JANUS KINASE 2 INHIBITORS |
| 3KB7 | A: | CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR |
| 3KCK | A: | A NOVEL CHEMOTYPE OF KINASE INHIBITORS |
| 3KEX | A:; B: | CRYSTAL STRUCTURE OF THE CATALYTICALLY INACTIVE KINASE DOMAIN OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3) |
| 3KMU | A: | CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (APO) |
| 3KMW | A: | CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MGATP) |
| 3KRR | A: | CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT QUINOXALINE ATP SITE INHIBITOR |
| 3L9P | A: | CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN |
| 3LCS | A: | CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN |
| 3LCT | A: | CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN |
| 3LM0 | A: | CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE 17B (STK17B) |
| 3LM5 | A: | CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE 17B (STK17B) IN COMPLEX WITH QUERCETIN |
| 3LMG | A:; B: | CRYSTAL STRUCTURE OF THE ERBB3 KINASE DOMAIN IN COMPLEX WITH AMP-PNP |
| 3LPB | A:; B: | CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT 2,8-DIARYL-QUINOXALINE INHIBITOR |
| 3LXK | A: | STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 |
| 3LXL | A: | STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 |
| 3LXN | A: | STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 |
| 3LXP | A: | STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 |
| 3LZB | A:; B:; C:; D: | EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[2,1-B]THIAZOLE INHIBITOR |
| 3MFR | A: | CASK-4M CAM KINASE DOMAIN, NATIVE |
| 3MFS | A: | CASK-4M CAM KINASE DOMAIN, AMPPNP |
| 3MFT | A: | CASK-4M CAM KINASE DOMAIN, MN2+ |
| 3MFU | A: | CASK-4M CAM KINASE DOMAIN, AMPPNP-MN2+ |
| 3NYX | A: | NON-PHOSPHORYLATED TYK2 JH1 DOMAIN WITH QUINOLINE-THIADIAZOLE-THIOPHENE INHIBITOR |
| 3NZ0 | A: | NON-PHOSPHORYLATED TYK2 KINASE WITH CMP6 |
| 3ORX | A:; B:; C:; D:; E:; F:; G:; H: | PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8 |
| 3ORZ | A:; B:; C:; D: | PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2 |
| 3OTU | A: | PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR JS30 |
| 3PJC | A: | CRYSTAL STRUCTURE OF JAK3 COMPLEXED WITH A POTENT ATP SITE INHIBITOR SHOWING HIGH SELECTIVITY WITHIN THE JANUS KINASE FAMILY |
| 3PPK | A:; B: | HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR |
| 3Q32 | A:; B: | STRUCTURE OF JANUS KINASE 2 WITH A PYRROLOTRIAZINE INHIBITOR |
| 3Q4T | A:; B: | CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DORSOMORPHIN |
| 3Q96 | A:; B: | B-RAF KINASE DOMAIN IN COMPLEX WITH A TETRAHYDRONAPHTHALENE INHIBITOR |
| 3QCQ | A: | PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-(3-AMINO-1H-INDAZOL-6-YL)-N4-ETHYL-2,4-PYRIMIDINEDIAMINE |
| 3QCS | A: | PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-[2-AMINO-6-(4-MORPHOLINYL)-4-PYRIMIDINYL]-1H-INDAZOL-3-AMINE |
| 3QCX | A: | PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-{2-AMINO-6-[(3R)-3-METHYL-4-MORPHOLINYL]-4-PYRIMIDINYL}-1H-INDAZOL-3-AMINE |
| 3QCY | A: | PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 4-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-N-PHENYL-2-MORPHOLINECARBOXAMIDE |
| 3QD0 | A: | PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH (2R,5S)-1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-6-METHYL-N-PHENYL-3-PIPERIDINECARBOXAMIDE |
| 3QD3 | A: | PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 1,1-DIMETHYLETHYL {(3R,6S)-1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-6-METHYL-3-PIPERIDINYL}CARBAMATE |
| 3QD4 | A: | PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 1,1-DIMETHYLETHYL{(3R,5R)-1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-5-METHYL-3-PIPERIDINYL}CARBAMATE |
| 3REP | A: | CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MNATP) |
| 3RVG | A: | CRYSTALS STRUCTURE OF JAK2 WITH A 1-AMINO-5H-PYRIDO[4,3-B]INDOL-4-CARBOXAMIDE INHIBITOR |
| 3SOC | A:; B: | CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH A QUINAZOLIN |
| 3THB | A: | STRUCTURE OF PLK1 KINASE DOMAIN IN COMPLEX WITH A BENZOLACTAM-DERIVED INHIBITOR |
| 3TJC | A:; B: | CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 8 |
| 3TJD | A:; B: | CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 19 |
| 3UGC | A: | STRUCTURAL BASIS OF JAK2 INHIBITION BY THE TYPE II INHIBTOR NVP-BBT594 |
| 3UIU | A:; B: | CRYSTAL STRUCTURE OF APO-PKR KINASE DOMAIN |
| 3V5Q | A:; B: | DISCOVERY OF A SELECTIVE TRK INHIBITOR WITH EFFICACY IN RODENT CANCER TUMOR MODELS |
| 3VN9 | A: | RIFINED CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED MAP2K6 IN A PUTATIVE AUTO-INHIBITION STATE |
| 3VQU | A: | CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2- YL)AMINO]BENZAMIDE |
| 3VW6 | A:; B: | CRYSTAL STRUCTURE OF HUMAN APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) WITH IMIDAZOPYRIDINE INHIBITOR |
| 3W1F | A: | CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 5-(5-ETHOXY-6-(1-METHYL-1H-PYRAZOL-4-YL)-1H-INDAZOL-3-YL)-2-METHYLBENZENESULFONAMIDE |
| 3ZBF | A: | STRUCTURE OF HUMAN ROS1 KINASE DOMAIN IN COMPLEX WITH CRIZOTINIB |
| 3ZDU | A: | CRYSTAL STRUCTURE OF THE HUMAN CDKL3 KINASE DOMAIN |
| 3ZEP | A:; B:; C:; D: | CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR |
| 3ZEW | A:; B: | CRYSTAL STRUCTURE OF EPHB4 IN COMPLEX WITH STAUROSPORINE |
| 3ZFM | A: | CRYSTAL STRUCTURE OF EPHB2 |
| 3ZFX | A:; B:; C:; D:; E:; F:; G:; H:; I: | CRYSTAL STRUCTURE OF EPHB1 |
| 3ZFY | A:; B: | CRYSTAL STRUCTURE OF EPHB3 |
| 3ZH8 | A:; B:; C: | A NOVEL SMALL MOLECULE APKC INHIBITOR |
| 3ZHP | C:; D: | HUMAN MST3 (STK24) IN COMPLEX WITH MO25BETA |
| 3ZMM | A:; B: | INHIBITORS OF JAK2 KINASE DOMAIN |
| 3ZOS | A:; B: | STRUCTURE OF THE DDR1 KINASE DOMAIN IN COMPLEX WITH PONATINIB |
| 3ZVV | A:726-1092 | FRAGMENT BOUND TO PI3KINASE GAMMA |
| 3ZW3 | A:726-1090 | FRAGMENT BASED DISCOVERY OF A NOVEL AND SELECTIVE PI3 KINASE INHIBITOR |
| 3ZZW | A:; B: | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF ROR2 |
| 4A06 | A: | HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC ACTIVATOR PS114 BOUND TO THE PIF-POCKET |
| 4A07 | A: | HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC ACTIVATOR PS171 BOUND TO THE PIF-POCKET |
| 4A4L | A: | CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 5-(2-AMINO-PYRIMIDIN-4-YL)-1H-PYRROLE INHIBITOR |
| 4A4O | A: | CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2-(2-AMINO-PYRIMIDIN-4-YL)-1,5,6,7-TETRAHYDRO-PYRROLOPYRIDIN-4-ONE INHIBITOR |
| 4A7C | A: | CRYSTAL STRUCTURE OF PIM1 KINASE WITH ETP46546 |
| 4A9R | A: | CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR |
| 4A9S | A: | CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR |
| 4A9T | A: | CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR |
| 4A9U | A: | CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR |
| 4AAA | A: | CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN |
| 4AGU | A:; B:; C: | CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN |
| 4ALV | A: | BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1 |
| 4ALW | A: | BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1 |
| 4ANL | A: | STRUCTURE OF G1269A MUTANT ANAPLASTIC LYMPHOMA KINASE |
| 4ANQ | A: | STRUCTURE OF G1269A MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB |
| 4ANS | A: | STRUCTURE OF L1196M,G1269A DOUBLE MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB |
| 4ANU | A:726-1087 | COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS. |
| 4ANV | A:726-1089 | COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS. |
| 4ANW | A:726-1087 | COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS. |
| 4ANX | A:726-1087 | COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS. |
| 4AOJ | A:; B:; C: | HUMAN TRKA IN COMPLEX WITH THE INHIBITOR AZ-23 |
| 4APC | A:; B: | CRYSTAL STRUCTURE OF HUMAN NIMA-RELATED KINASE 1 (NEK1) |
| 4APP | A: | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH (S)-N-(5-(3-BENZYL-1-METHYLPIPERAZINE-4-CARBONYL)-6,6-DIMETHYL-1,4,5,6-TETRAHYDROPYRROLO(3,4-C) PYRAZOL-3-YL)-3-PHENOXYBENZAMIDE |
| 4AQC | A:; B: | TRIAZOLOPYRIDINE-BASED INHIBITOR OF JANUS KINASE 2 |
| 4ASX | A:; B: | CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DIHYDRO-BAUERINE C |
| 4ASZ | A: | CRYSTAL STRUCTURE OF APO TRKB KINASE DOMAIN |
| 4AT3 | A: | CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH CPD5N |
| 4AT4 | A: | CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH EX429 |
| 4AT5 | A: | CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH GW2580 |
| 4AW0 | A: | HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND PS182 BOUND TO THE PIF-POCKET |
| 4AW1 | A: | HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND PS210 BOUND TO THE PIF-POCKET |
| 4AW5 | A: | COMPLEX OF THE EPHB4 KINASE DOMAIN WITH AN OXINDOLE INHIBITOR |
| 4B6L | A: | DISCOVERY OF ORAL POLO-LIKE KINASE (PLK) INHIBITORS WITH ENHANCED SELECTIVITY PROFILE USING RESIDUE TARGETED DRUG DESIGN |
| 4B99 | A: | CRYSTAL STRUCTURE OF MAPK7 (ERK5) WITH INHIBITOR |
| 4B9D | A:; B: | CRYSTAL STRUCTURE OF HUMAN NIMA-RELATED KINASE 1 (NEK1) WITH INHIBITOR. |
| 4BB4 | A: | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
| 4BBE | A:; B:; C:; D: | AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2 |
| 4BBF | A:; B:; C:; D: | AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2 |
| 4BBM | A:; B: | CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312 |
| 4BDA | A: | FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2) |
| 4BDB | A: | FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2) |
| 4BDC | A: | FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2) |
| 4BDD | A: | FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2) |
| 4BDE | A: | FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2) |
| 4BDF | A: | FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2) |
| 4BDG | A: | FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2) |
| 4BDH | A: | FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2) |
| 4BDI | A: | FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2) |
| 4BDJ | A: | FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2) |
| 4BF2 | A:; B: | CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES |
| 4BGQ | A: | CRYSTAL STRUCTURE OF THE HUMAN CDKL5 KINASE DOMAIN |
| 4BHN | A:; B: | CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES |
| 4BHZ | A: | SCAFFOLD FOCUSED VIRTUAL SCREENING: PROSPECTIVE APPLICATION TO THE DISCOVERY OF TTK INHIBITOR |
| 4BI0 | A: | SCAFFOLD FOCUSED VIRTUAL SCREENING: PROSPECTIVE APPLICATION TO THE DISCOVERY OF TTK INHIBITOR |
| 4BI1 | A: | SCAFFOLD FOCUSED VIRTUAL SCREENING: PROSPECTIVE APPLICATION TO THE DISCOVERY OF TTK INHIBITOR |
| 4BI2 | A: | SCAFFOLD FOCUSED VIRTUAL SCREENING: PROSPECTIVE APPLICATION TO THE DISCOVERY OF TTK INHIBITOR |
| 4BIB | A:; B: | CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES |
| 4BIC | A:; B: | CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES |
| 4BID | A:; B: | CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES |
| 4BIE | A:; B: | CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES |
| 4BKJ | A:; B: | CRYSTAL STRUCTURE OF THE HUMAN DDR1 KINASE DOMAIN IN COMPLEX WITH IMATINIB |
| 4BN1 | A: | CRYSTAL STRUCTURE OF V174M MUTANT OF AURORA-A KINASE |
| 4BTJ | A:; B: | TTBK1 IN COMPLEX WITH ATP |
| 4BTK | A: | TTBK1 IN COMPLEX WITH INHIBITOR |
| 4BTM | A:; B: | TTBK1 IN COMPLEX WITH INHIBITOR |
| 4C4E | A: | STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1 |
| 4C4F | A: | STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1 |
| 4C4G | A: | STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1 |
| 4C4H | A: | STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1 |
| 4C4I | A: | STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1 |
| 4C4J | A: | STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1 |
| 4C61 | A:; B: | INHIBITORS OF JAK2 KINASE DOMAIN |
| 4C62 | A:; B: | INHIBITORS OF JAK2 KINASE DOMAIN |
| 4CCB | A: | STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 3-((R)-1-(5-FLUORO-2-(2H-1,2,3-TRIAZOL-2-YL) PHENYL)ETHOXY)-5-(5-METHYL-1H-PYRAZOL-4-YL)PYRIDIN-2-AMINE |
| 4CCU | A: | STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 2-(5-(6-AMINO-5-((R)-1-(5-FLUORO-2-(2H-1,2,3-TRIAZOL-2-YL) PHENYL)ETHOXY)PYRIDIN-3-YL)-4-METHYLTHIAZOL-2-YL)PROPAN-2-OL |
| 4CD0 | A: | STRUCTURE OF L1196M MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 2-(5-(6-AMINO-5-((R)-1-(5-FLUORO-2-(2H-1,2,3-TRIAZOL-2-YL) PHENYL)ETHOXY)PYRIDIN-3-YL)-4-METHYLTHIAZOL-2-YL)PROPANE-1,2-DIOL |
| 4CKI | A: | CRYSTAL STRUCTURE OF ONCOGENIC RET TYROSINE KINASE M918T BOUND TO ADENOSINE |
| 4CKJ | A: | CRYSTAL STRUCTURE OF RET TYROSINE KINASE DOMAIN BOUND TO ADENOSINE |
| 4CKR | A: | CRYSTAL STRUCTURE OF THE HUMAN DDR1 KINASE DOMAIN IN COMPLEX WITH DDR1-IN-1 |
| 4CRS | A: | HUMAN PROTEIN KINASE N2 (PKN2, PRKCL2) IN COMPLEX WITH ATPGAMMAS |
| 4D9T | A: | RSK2 C-TERMINAL KINASE DOMAIN WITH INHIBITOR (E)-METHYL 3-(4-AMINO-7-(3-HYDROXYPROPYL)-5-P-TOLYL-7H-PYRROLO[2,3-D]PYRIMIDIN-6-YL)-2-CYANOACRYLATE |
| 4DCE | A:; B: | CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH A PIPERIDINE-CARBOXAMIDE INHIBITOR |
| 4E4L | A:; B:; D:; E: | JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30 |
| 4E4M | A:; B:; D:; E: | JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30 |
| 4E4N | A:; B: | JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 49 |
| 4E5W | A:; B: | JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 26 |
| 4E6D | A:; B: | JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 7 |
| 4E6Q | A:; B: | JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 12 |
| 4EHZ | A:; B:; C:; D: | THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR |
| 4EI4 | A:; B: | JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 20 |
| 4F08 | A:; B: | DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2 |
| 4F09 | A: | DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2 |
| 4F0I | A:; B: | CRYSTAL STRUCTURE OF APO TRKA |
| 4FIG | A:; B: | CATALYTIC DOMAIN OF HUMAN PAK4 |
| 4FIH | A: | CATALYTIC DOMAIN OF HUMAN PAK4 WITH QKFTGLPRQW PEPTIDE |
| 4FIJ | A: | CATALYTIC DOMAIN OF HUMAN PAK4 |
| 4FK3 | A:; B: | B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX3203 |
| 4FK6 | A:; B: | JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 72 |
| 4FNW | A: | CRYSTAL STRUCTURE OF THE APO F1174L ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN |
| 4FNX | A: | CRYSTAL STRUCTURE OF THE APO R1275Q ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN |
| 4FNY | A: | CRYSTAL STRUCTURE OF THE R1275Q ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR |
| 4FNZ | A: | CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PIPERIDINE-CARBOXAMIDE INHIBITOR 2 |
| 4FOB | A: | CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 1 |
| 4FOC | A: | CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 2 |
| 4FOD | A: | CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 36 |
| 4FVP | A: | CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN (APO FORM) |
| 4FVQ | A: | CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN (MG-ATP-BOUND FORM) |
| 4FVR | A: | CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN MUTANT V617F (MG-ATP-BOUND FORM) |
| 4FZA | B: | CRYSTAL STRUCTURE OF MST4-MO25 COMPLEX |
| 4G2F | A: | HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH COMPOUND 7 |
| 4G31 | A: | CRYSTAL STRUCTURE OF GSK6414 BOUND TO PERK (R587-R1092, DELETE A660-T867) AT 2.28 A RESOLUTION |
| 4G34 | A: | CRYSTAL STRUCTURE OF GSK6924 BOUND TO PERK (R587-R1092, DELETE A660-T867) AT 2.70 A RESOLUTION |
| 4GFM | A: | JAK2 KINASE (JH1 DOMAIN) WITH 2,6-DICHLORO-N-(2-OXO-2,5-DIHYDROPYRIDIN-4-YL)BENZAMIDE |
| 4GFO | A: | TYK2 KINASE (JH1 DOMAIN) WITH 2,6-DICHLORO-N-(2-OXO-2,5-DIHYDROPYRIDIN-4-YL)BENZAMIDE |
| 4GIH | A: | TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-N-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}BENZAMIDE |
| 4GII | A: | TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-4-CYANO-N-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE |
| 4GJ2 | A: | TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-N-[2-({[(1R,2R)-2-FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE |
| 4GJ3 | A: | TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-4-CYANO-N-[2-({[(1R,2R)-2-FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE |
| 4GK2 | A: | HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 66 |
| 4GK3 | A: | HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 87 |
| 4GK4 | A: | HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 90 |
| 4GMY | A: | JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH 2,6-DICHLORO-N-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE |
| 4GT4 | A:; B: | STRUCTURE OF UNLIGANDED, INACTIVE ROR2 KINASE DOMAIN |
| 4GT5 | A: | CRYSTAL STRUCTURE OF THE INACTIVE TRKA KINASE DOMAIN |
| 4GVJ | A: | TYK2 (JH1) IN COMPLEX WITH ADENOSINE DI-PHOSPHATE |
| 4HGE | A:; B: | JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 8 |
| 4HLE | A:726-1092 | COMPOUND 21 (1-ALKYL-SUBSTITUTED 1,2,4-TRIAZOLES) |
| 4HVD | A: | JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ((S)-1,2,2-TRIMETHYL-PROPYL)-AMIDE |
| 4HVG | A: | JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ((S)-2-HYDROXY-1,2-DIMETHYL-PROPYL)-AMIDE |
| 4HVH | A: | JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ((R)-2-HYDROXY-1,2-DIMETHYL-PROPYL |
| 4HVI | A: | JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ((R)-1-METHYL-2-OXO-2-PIPERIDIN-1-YL-ETHYL)-AMIDE |
| 4I5C | A:; B: | THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR |
| 4I5P | A: | SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN |
| 4I6B | A: | SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN |
| 4I6F | A: | SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN |
| 4I6H | A: | SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE ALPHA-SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN |
| 4I6Q | A: | JAK3 KINASE DOMAIN IN COMPLEX WITH 2-PHENOXY-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ((S)-1-CYCLOPROPYL-ETHYL)-AMIDE |
| 4IC7 | A:; D: | CRYSTAL STRUCTURE OF THE ERK5 KINASE DOMAIN IN COMPLEX WITH AN MKK5 BINDING FRAGMENT |
| 4IC8 | A:; B: | CRYSTAL STRUCTURE OF THE APO ERK5 KINASE DOMAIN |
| 4ITH | A:; B: | CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-1 ANALOG |
| 4ITI | A:; B: | CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-3 ANALOG |
| 4ITJ | A:; B: | CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-4 |
| 4IVA | A: | JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-[(8AS)-2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(8AH)-YL]CYCLOHEXANECARBONITRILE |
| 4IVB | A:; B: | JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-{2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(6H)-YL}CYCLOHEXANECARBONITRILE |
| 4IVC | A:; B: | JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR (TRANS-4-{2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(6H)-YL}CYCLOHEXYL)ACETONITRILE |
| 4IVD | A:; B: | JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 34 |
| 4J52 | A: | CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH A PYRIMIDODIAZEPINONE INHIBITOR |
| 4J53 | A: | CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH TAK-960 |
| 4J6I | A:726-1087 | DISCOVERY OF THIAZOLOBENZOXEPIN PI3-KINASE INHIBITORS THAT SPARE THE PI3-KINASE BETA ISOFORM |
| 4JDH | A: | CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 IN COMPLEX WITH PAKTIDE T PEPTIDE SUBSTRATE |
| 4JDI | A: | CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 IN COMPLEX WITH PAKTIDE S PEPTIDE SUBSTRATE |
| 4JDJ | A: | CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 F461V MUTANT IN COMPLEX WITH PAKTIDE T PEPTIDE SUBSTRATE |
| 4JDK | A: | CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 F461V MUTANT IN COMPLEX WITH PAKTIDE S PEPTIDE SUBSTRATE |
| 4JI9 | A:; B: | JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH TG101209 |
| 4JIA | A: | JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 9 |
| 4JOA | A: | CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 7-AZAINDOLE BASED INHIBITOR |
| 4JS8 | A: | CRYSTAL STRUCTURE OF TTK KINASE DOMAIN WITH AN INHIBITOR: 401348 |
| 4JT3 | A: | CRYSTAL STRUCTURE OF TTK KINASE DOMAIN WITH AN INHIBITOR: 400740 |
| 4JVG | A:; B:; C:; D: | B-RAF KINASE IN COMPLEX WITH BIRB796 |
| 4JXF | A: | CRYSTAL STRUCTURE OF PLK4 KINASE WITH AN INHIBITOR: 400631 ((1R,2S)-2-{3-[(E)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}ETHENYL]-2H-INDAZOL-6-YL}-5'-METHOXYSPIRO[CYCLOPROPANE-1,3'-INDOL]-2'(1'H)-ONE) |
| 4K6Z | A: | THE JAK1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 37 |
| 4K77 | A:; B: | JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 6 |
| 4KS7 | A: | PAK6 KINASE DOMAIN IN COMPLEX WITH PF-3758309 |
| 4KS8 | A: | PAK6 KINASE DOMAIN IN COMPLEX WITH SUNITINIB |
| 4L00 | A:; B: | CRYSTAL STRUCTURE OF THE APO JAK1 PSEUDOKINASE DOMAIN |
| 4L01 | A:; B: | CRYSTAL STRUCTURE OF THE V658F APO JAK1 PSEUDOKINASE DOMAIN |
| 4L3J | A: | CRYSTAL STRUCTURES OF HUMAN P70S6K1 KINASE DOMAIN |
| 4L3L | A: | CRYSTAL STRUCTURES OF HUMAN P70S6K1 KINASE DOMAIN (ZINC ANOMALOUS) |
| 4L42 | A: | CRYSTAL STRUCTURES OF HUMAN P70S6K1-PIF |
| 4L43 | A: | CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389A (FORM I) |
| 4L44 | A: | CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389A (FORM II) |
| 4L45 | A: | CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389E |
| 4L46 | A: | CRYSTAL STRUCTURES OF HUMAN P70S6K1-WT |
| 4L67 | A: | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF PAK4 |
| 4LG4 | A:; B:; C:; D:; E:; F: | STRUCTURAL BASIS FOR AUTOACTIVATION OF HUMAN MST2 KINASE AND ITS REGULATION BY RASSF5 |
| 4M67 | A: | CRYSTAL STRUCTURE OF THE HUMAN MLKL KINASE-LIKE DOMAIN |
| 4MKC | A: | CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE COMPLEXED WITH LDK378 |
| 4MWI | A: | CRYSTAL STRUCTURE OF THE HUMAN MLKL PSEUDOKINASE DOMAIN |
| 4NFM | A: | HUMAN TAU TUBULIN KINASE 1 (TTBK1) |
| 4NFN | A: | HUMAN TAU TUBULIN KINASE 1 (TTBK1) COMPLEXED WITH 3-({5-[(4-AMINO-4-METHYLPIPERIDIN-1-YL)METHYL]PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL}AMINO)-5-BROMOPHENOL |
| 4NUS | A: | RSK2 N-TERMINAL KINASE IN COMPLEX WITH LJH685 |
| 4NW5 | A:51-346 | RSK2 N-TERMINAL KINASE IN COMPLEX WITH 2-AMINO-7-SUBSTITUTED BENZOXAZOLE COMPOUND 8 |
| 4NW6 | A:51-346 | RSK2 N-TERMINAL KINASE IN COMPLEX WITH 2-AMINO-7-SUBSTITUTED BENZOXAZOLE COMPOUND 27 |
| 4O0R | A:; B: | BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS |
| 4O0T | A:; B: | BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS |
| 4O0V | A: | BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS |
| 4O0X | A: | BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS |
| 4O0Y | A: | BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS |
| 4OTW | A: | HER3 PSEUDOKINASE DOMAIN BOUND TO BOSUTINIB |
)
)